FDA approves pill treatment for pancreatic cancer priced at $477,000 annually

Verifying
  • FDA approved a pill-form treatment for a common pancreatic cancer type.
  • $477,000 is the treatment’s approximate annual list price.
  • Patient costs vary with insurance coverage and financial assistance eligibility.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.